Ngo, Yen

Publishing since 2002 (Junior)

Has published 17 publications in 8 years

Number of publications published per year by Ngo, Yen. (Source : PubMed)

Distribution of publications types for Ngo, Yen. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Poynard T, Munteanu M, Ngo Y, Ratziu V. Appropriate evidence-based data overviews demonstrate the diagnostic and prognostic performances of FibroTest in patients with chronic hepatitis C.  Aliment. Pharmacol. Ther.  2009;30;11-12  
•  Poynard T, Massard J, Rudler M, Varaud A, Lebray P, Moussalli J, Munteanu M, Ngo Y, Thabut D, Benhamou Y, Ratziu V. Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials.  Gastroenterol. Clin. Biol.  2009;33;10-11  
•  Ingiliz P, Chhay KP, Munteanu M, Lebray P, Ngo Y, Roulot D, Benhamou Y, Thabut D, Ratziu V, Poynard T. Applicability and variability of liver stiffness measurements according to probe position.  World J. Gastroenterol.  2009;15;27  
•  Munteanu M, Ngo Y, Ratziu V, Poynard T. The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests".  Gastroenterol. Clin. Biol.  2009;33;5  
•  Ngo Y, Advani R, Valentini D, Gaseitsiwe S, Mahdavifar S, Maeurer M, Reilly M. Identification and testing of control peptides for antigen microarrays.  J. Immunol. Methods  2009;343;2  
•  Poynard T, Ngo Y, Marcellin P, Hadziyannis S, Ratziu V, Benhamou Y. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus.  J. Viral Hepat.  2009;16;3  
•  Munteanu M, Lebray P, Massard J, Moussalli J, Varaut A, Ngo Y, Thabut D, Imbert-Bismut F, Benhamou Y, Ratziu V, Poynard T. Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux".  Gastroenterol. Clin. Biol.  2009;33;2  
•  Naveau S, Gaudé G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prévot S, Ngo Y, Munteanu M, Balian A, Njiké-Nakseu M, Perlemuter G, Poynard T. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.  Hepatology  2009;49;1  
•  Poynard T, Muntenau M, Morra R, Ngo Y, Imbert-Bismut F, Thabut D, Messous D, Massard J, Lebray P, Moussalli J, Benhamou Y, Ratziu V. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update.  Gastroenterol. Clin. Biol.  2008;32;6 Suppl 1  
•  Poynard T, Munteanu M, Ngo Y, Moussalli J, Lebray P, Thabut D, Benhamou Y, Ratziu V. FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.  J. Viral Hepat.  2008;15;6  

[ See timeline ] [ See all publications ]